Skip to main content

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 11441 - 11460 of 45042
Advocacy Filings

FTC Staff Comment Before the Food and Drug Administration Regarding the Current Use of Human Drug and Biological Products Labeled As Homeopathic, and the FDA's Regulatory Framework For Such Products

Date
Matter Number
P114505
Docket Number
80 Fed. Reg. 16327 (Mar. 27, 2015)
FTC staff has recommended that the U.S. Food and Drug Administration (FDA) reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s...
Related Release
FTC Staff Comment: FDA Should Reevaluate Its Current Regulatory Framework for Homeopathic Products
Displaying 11441 - 11460 of 45042
Return to top